N-Acetylcysteine and Milk Thistle for Treatment of Diabetic Nephropathy
Status:
Completed
Trial end date:
2016-12-01
Target enrollment:
Participant gender:
Summary
The study is done to find out whether the combined use of the nutritional supplements
N-acetylcysteine and Siliphos (milk thistle extract) corrects the shedding of urine protein
and oxidative damage (damage to cells and organs often compared to fast aging) in patients
with Type 2 Diabetes Mellitus (T2DM) and diabetic kidney disease.
Phase:
Phase 2
Details
Lead Sponsor:
VA Office of Research and Development
Collaborator:
National Center for Complementary and Integrative Health (NCCIH)